Logos Global Management LP Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$1071.3T
Holdings
50
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (50 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CYTKCYTOKINETICS INC | 1,625,000 | $135.7T | 12.66% | |
| 2 | APLSAPELLIS PHARMACEUTICALS INC | 1,950,000 | $116.7T | 10.90% | Call |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 700,000 | $67.5T | 6.30% | Call |
| 4 | IDYAIDEAYA BIOSCIENCES INC | 1,800,000 | $64.0T | 5.98% | |
| 5 | ARGXARGENX SE | 145,000 | $55.2T | 5.15% | |
| 6 | OLMAOLEMA PHARMACEUTICALS INC | 4,383,875 | $54.4T | 5.08% | |
| 7 | IMVTIMMUNOVANT INC | 1,200,000 | $50.6T | 4.72% | |
| 8 | GPCRSTRUCTURE THERAPEUTICS INC | 1,070,058 | $43.6T | 4.07% | |
| 9 | RCKTROCKET PHARMACEUTICALS INC | 1,275,000 | $38.2T | 3.57% | |
| 10 | —RAYZEBIO INC | 568,173 | $35.3T | 3.30% | |
| 11 | AMAMAMBRX BIOPHARMA INC | 2,100,000 | $29.9T | 2.79% | |
| 12 | KRTXKARUNA THERAPEUTICS INC | 90,000 | $28.5T | 2.66% | |
| 13 | IMCRIMMUNOCORE HLDGS PLC | 400,000 | $27.3T | 2.55% | |
| 14 | DYNDYNE THERAPEUTICS INC | 1,880,000 | $25.0T | 2.33% | |
| 15 | MOR2MORPHOSYS AG | 2,475,000 | $24.5T | 2.29% | Call |
| 16 | INBXUSDINHIBRX INC | 600,000 | $22.8T | 2.13% | Call |
| 17 | ANNXANNEXON INC | 4,950,000 | $22.5T | 2.10% | |
| 18 | AKROAKERO THERAPEUTICS INC | 800,000 | $18.7T | 1.74% | |
| 19 | OCULOCULAR THERAPEUTIX INC | 4,000,000 | $17.8T | 1.67% | |
| 20 | DSGNDESIGN THERAPEUTICS INC | 5,032,501 | $13.3T | 1.24% | |
| 21 | VRDNVIRIDIAN THERAPEUTICS INC | 600,000 | $13.1T | 1.22% | |
| 22 | EWTXEDGEWISE THERAPEUTICS INC | 950,000 | $10.4T | 0.97% | |
| 23 | RVMDREVOLUTION MEDICINES INC | 350,000 | $10.0T | 0.94% | |
| 24 | SLRNACELYRIN INC | 1,250,000 | $9.3T | 0.87% | |
| 25 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 150,000 | $9.1T | 0.85% | |
| 26 | ATYRATYR PHARMA INC | 5,850,000 | $8.2T | 0.77% | |
| 27 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,000,000 | $8.1T | 0.76% | Call |
| 28 | FULCFULCRUM THERAPEUTICS INC | 1,200,000 | $8.1T | 0.76% | |
| 29 | ALLKGUSDALLAKOS INC | 2,900,000 | $7.9T | 0.74% | |
| 30 | ZNTLZENTALIS PHARMACEUTICALS INC | 500,000 | $7.6T | 0.71% | Call |
| 31 | TRMLTOURMALINE BIO INC | 284,372 | $7.4T | 0.69% | |
| 32 | RNAAVIDITY BIOSCIENCES INC | 775,000 | $7.0T | 0.65% | |
| 33 | SLNSILENCE THERAPEUTICS PLC | 400,000 | $6.9T | 0.65% | |
| 34 | XENEXENON PHARMACEUTICALS INC | 150,000 | $6.9T | 0.64% | |
| 35 | NMRANEUMORA THERAPEUTICS INC. | 382,345 | $6.5T | 0.61% | |
| 36 | RCUSARCUS BIOSCIENCES INC | 325,000 | $6.2T | 0.58% | |
| 37 | MORFMORPHIC HLDG INC | 200,000 | $5.8T | 0.54% | |
| 38 | APLTAPPLIED THERAPEUTICS INC | 1,660,000 | $5.6T | 0.52% | |
| 39 | VTYXVENTYX BIOSCIENCES INC | 2,000,000 | $4.9T | 0.46% | |
| 40 | —ICOSAVAX INC | 300,000 | $4.7T | 0.44% | |
| 41 | RPTXREPARE THERAPEUTICS INC | 600,000 | $4.4T | 0.41% | |
| 42 | CMPSCOMPASS PATHWAYS PLC | 500,000 | $4.4T | 0.41% | |
| 43 | ELVNENLIVEN THERAPEUTICS INC | 307,076 | $4.2T | 0.40% | |
| 44 | CATBUSDASTRIA THERAPEUTICS INC | 544,960 | $4.2T | 0.39% | |
| 45 | SYRESPYRE THERAPEUTICS INC | 150,000 | $3.2T | 0.30% | |
| 46 | KNSAKINIKSA PHARMACEUTICALS LTD | 150,000 | $2.6T | 0.25% | |
| 47 | DCTHDELCATH SYS INC | 300,000 | $1.2T | 0.12% | |
| 48 | IOBTIO BIOTECH INC | 493,827 | $928.4B | 0.09% | |
| 49 | IMUXIMMUNIC INC | 421,184 | $631.8B | 0.06% | |
| 50 | NUVB/WSNUVATION BIO INC | 66,666 | $4.0B | 0.00% |